Glycobiology Market | Drug discovery research driving growth in global market

The global glycobiology market is expected to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%.

(firmenpresse) - According to a new market research report "Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021", published by MarketsandMarkets, the global market is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3% during the forecast period.

Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of this market.

Don’t miss out the business opportunities in global Glycobiology Market.

Browse and in-depth TOC on "Glycobiology Market"
91 – Tables
32 - Figures
158 - Pages

Download an Illustrative overview of the report @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525

The global Glycomics/Glycobiology Market is broadly segmented into product, application, end user, and region. On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. In 2016, the enzymes segment is expected to account for the largest share of the global Glycomics/Glycobiology Market. The enzymes segment is further categorized into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes. In 2016, the glycosidases segment is expected to account for the largest share of the market owing to its consumable nature, vast applications of glycosidase enzymes in R&D, and drug development processes.

On the basis of application, the market is segmented into diagnostics, drug discovery and development, immunology, oncology, and other applications. In 2016, the drug discovery and development segment is expected to command the largest share and grow at the highest CAGR during the forecast period. The large share and high growth in this segment can be attributed to the increase in R&D activities for the development of novel drugs and therapies.



On the basis of end user, the market is segmented into academic research institutes, pharmaceutical & biotechnology companies, and contract research organizations. In 2016, the academic research institutes segment is expected to account for the largest share of the market. This growth can be attributed to the rising availability of funding for life science research.

On the basis of region, the market was dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).

In 2015, North America accounted for the largest share of the market, while Asia witnessed the highest growth rate mainly due to increasing commercialization of pharmaceutical and biotechnology research, increasing awareness about personalized medicine, and rising importance of companion diagnostics.

Major players in the Glycobiology Market include are Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525
Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
PresseKontakt / Agentur:
Bereitgestellt von Benutzer: dheerajshaha67
Datum: 28.05.2019 - 11:10 Uhr
Sprache: Deutsch
News-ID 1724531
Anzahl Zeichen: 3647

Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:

Northbrook

Telefon: 18886006441

Kategorie:

Biotechnologie

Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 28.05.2019

Diese Pressemitteilung wurde bisher 391 mal aufgerufen.

Microplate Systems Market | Increasing R&D Expenditure in the Pharmaceutical Industry ...
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. The report "Microplate Systems Market by Product (Microplate R

3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years ...
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private

Immuno Oncology Assays : Research Application Transforming the Industrial Business ...
What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report "Immuno Onco

Weitere Mitteilungen von MnM

Autosamplers Market Insights | Major drivers, Restraints, Opportunities and Challenges ...
According to a new market research report "Autosamplers Market by Product (Systems (Liquid Chromatography, GC (Liquid, Headspace, All-in-one)), Accessories (Syringe & Needle, Vial, Septum) & Enduser (Pharmaceutical companies, Oil & Gas, Food & Beverage, Environment testing) - Gl

Strategic Ways To Accelerate Your Revenue Growth In Epigenetics Market ...
According to a new market research report "Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022&q

Patient Derived Xenograft Models Market Size, Growth Analysis ...
According to a new market research report "Patient Derived Xenograft/PDx Models Market by Type (Mouse & Rat), Tumor Type (Gastrointestinal, Gynecological, Respiratory), Application (Pre-Clinical Drug Development & Biomarker Analysis), End User (Pharma & Biotech, CRO) - Global Foreca

Ovid Therapeutics präsentiert Ergebnisse am 12. International Epilepsy Colloquium ...
Ovid Therapeutics Inc. (NASDAQ: OVID), ein Biopharmaunternehmen, das Medikamente entwickelt, die das Leben von Menschen mit seltenen neurologischen Erkrankungen verbessern, präsentiert Daten bezüglich Sicherheit, Verträglichkeit sowie exploratorischer und sekundärer Ergebnisse der Phase 1b/2a